ProgressImage ProgressImage
Acutaas Chemicals Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 543349 border-img ISIN Demat INE00FF01025 border-img Book Value 173.03 border-img NSE Symbol ACUTAAS border-img Div & Yield % 0.08 border-img Market Cap ( Cr.) 14464.58 border-img P/E 64.08 border-img EPS 27.57 border-img Face Value 5
ParticularsMar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
Mar 2020
()
INCOME :       
Sales Turnover 989.83687.58616.73520.14340.61239.64
Excise Duty 0.000.000.000.000.000.00
Net Sales 989.83687.58616.73520.14340.61239.64
Other Income 18.3413.794.322.761.332.77
Stock Adjustments 18.6526.9414.969.50-4.818.99
Total Income 1026.82728.31636.01532.40337.13251.40
EXPENDITURE :       
Raw Materials 566.84434.96345.85282.33174.87137.90
Power & Fuel Cost 29.9925.6922.2821.405.264.53
Employee Cost 80.9560.9248.8441.3720.9912.77
Other Manufacturing Expenses 51.2347.4646.7149.5340.6534.60
Selling & Administrative Expenses 45.8432.3336.5627.2211.4715.37
Miscellaneous Expenses 8.4937.268.782.612.352.36
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 783.34638.61509.03424.45255.59207.55
Operating Profit 243.4889.69126.98107.9481.5343.86
Interest 5.865.892.416.415.625.59
Gross Profit 237.6283.80124.57101.5375.9138.27
Depreciation 24.0514.6912.3410.084.193.52
Profit Before Tax 213.5769.11112.2391.4571.7234.75
Tax 46.9720.9126.3816.7217.566.80
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 7.064.512.502.780.160.49
Reported Net Profit 159.5543.6883.3471.9554.0027.47
Extraordinary Items 1.55-15.35-0.55-0.10-0.61-0.69
Adjusted Net Profit 158.0059.0383.8972.0554.6128.16
Adjustment below Net Profit -0.11-0.090.170.00-21.03-0.63
P & L Balance brought forward 308.24275.58203.00131.2897.4870.64
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 12.2810.9310.930.000.000.00
P & L Balance carried down 455.40308.24275.58203.23130.4597.48
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 30.0030.0030.0030.000.000.00
Dividend Per Share(Rs) 1.503.003.003.000.000.00
Earnings Per Share-Unit Curr 19.4911.8422.8719.7517.1426.16
Earnings Per Share(Adj)-Unit Curr 9.755.9211.449.8817.1426.16
Book Value-Unit Curr 160.21183.05161.04142.1652.05102.84
Book Value(Adj)-Unit Curr 80.1191.5380.5271.0852.05102.84

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
close
refresh